Need help paying for your SYLVANT® (siltuximab) prescription?
We want to guide you to programs that may help. Here you'll find the financial assistance programs available for SYLVANT®. We have also listed most of the eligibility requirements for each, so you can narrow your focus to those that best suit your circumstances. Call the programs or visit their websites to learn more.
You may be eligible for one or more of the following programs:
At the current time, patient affordability programs for the selected insurance option are not available for this product. Please check back, as programs change.
The following program(s) is (are) affiliated with Janssen.
They are updated on a regular basis. Be sure to visit the program site for additional information.
Janssen CarePath Savings Program for SYLVANT®
If you are eligible, you may be able to lower your out-of-pocket medication costs for SYLVANT®. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. With the Janssen CarePath Savings Program for SYLVANT®, eligible patients pay $5 for each infusion for your medication costs, with a $20,000 maximum program benefit each calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. See full eligibility requirements.
The following programs are not affiliated with Janssen.
Be sure to contact the programs directly to get details on eligibility and application requirements, and to see if they have funding available to help you.
State-Sponsored Programs
Some states sponsor prescription financial assistance programs, each with its own eligibility requirements.
Many states have programs for people with limited income and resources that pay some or all of Medicare's premiums and may pay Medicare deductibles and co-insurance.
Medicare patients who have limited income and resources may qualify for "extra help" to pay for prescription drugs. The Low-Income Subsidy (LIS) program from Medicare provides financial assistance for patients who may otherwise be unable to afford the costs associated with their Medicare Part D plan.
Those who are eligible for LIS may:
Receive assistance paying their monthly premium
Have a reduced or no deductible
Have reduced or no prescription co-insurance and co-payments
Independent co-pay assistance foundations have their own rules for eligibility. We cannot guarantee a foundation will help you. We only can refer you to a foundation that supports your disease state. This information is provided as a resource for you. We do not endorse any particular foundation. The foundations on this list are not the only ones that might be able to help you.
Other Resources
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization that is committed to helping eligible patients without insurance coverage receive prescription products donated by Johnson & Johnson operating companies. To see if you might qualify for assistance, please contact a JJPAF program specialist at 1-800-652-6227 (Monday – Friday, 9:00 AM to 6:00 PM ET) or visit the foundation website at www.JJPAF.org.
SYLVANT® (siltuximab) is a prescription medicine used to treat people with multicentric Castleman's disease (MCD) who do not have human immunodeficiency virus (HIV) and human herpesvirus-8 (HHV-8) infection.
It is not known if SYLVANT® is safe and effective in children.
Who should not receive SYLVANT®?
Do not receive SYLVANT® if you have had a severe allergic reaction to siltuximab or any of the ingredients in SYLVANT®.
Before you receive SYLVANT®, tell your healthcare provider about all of your medical conditions, including if you:
have an infection. You should not receive SYLVANT® if you have a severe infection.
have had a recent vaccination or are scheduled to receive any vaccinations. You should not receive a live vaccine during your treatment with SYLVANT®.
have or have had any stomach or bowel (intestine) problems, such as diverticulitis or ulcers. Tell your healthcare provider if you have pain in your stomach area.
are pregnant or plan to become pregnant. It is not known if SYLVANT® will harm your unborn baby. You should not become pregnant while receiving treatment with SYLVANT®. Females who are able to become pregnant should use effective birth control during treatment with SYLVANT® and for 3 months after stopping treatment.
are breastfeeding or plan to breastfeed. It is not known if SYLVANT® passes into your breast milk. You and your healthcare provider should decide if you will take SYLVANT® or breastfeed. You should not do both.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of SYLVANT®?
SYLVANT® may cause serious side effects, including:
Infections. SYLVANT® may lower your ability to fight infections. Tell your healthcare provider right away if you have any signs or symptoms of an infection during treatment with SYLVANT®.
Infusion and allergic reactions. If you have an infusion or allergic reaction while receiving SYLVANT®, your healthcare provider will stop your infusion and treat your reaction. If you have a severe infusion or allergic reaction your healthcare provider may stop your treatment completely. Tell your healthcare provider or get medical help right away if you have any of these symptoms during or after your infusion of SYLVANT®: back pain, chest pain or tightness, nausea and vomiting, flushing, redness, irregular heart beat (palpitations), trouble breathing, wheezing, dizziness or light-headedness, swelling of the lips, skin rash, headache or itching.
The most common side effects of SYLVANT® include: rash, itching, upper respiratory tract infection, swelling, weight gain, and increased blood level of uric acid.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of SYLVANT®. Call your doctor for medical advice about side effects.
General information about the safe and effective use of SYLVANT®
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about SYLVANT® that is written for health professionals.
Report any signs of new or worsening medical conditions to your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Please click here to read Important Product Information for SYLVANT® and discuss any questions you have with your doctor.
cp-61151v1
Important Safety Information
What is SYLVANT®?
SYLVANT® (siltuximab) is a prescription medicine used to treat people with multicentric Castleman's disease (MCD) who do not have human immunodeficiency virus (HIV) and human herpesvirus-8 (HHV-8) infection.
It is not known if SYLVANT® is safe and effective in children.
Who should not receive SYLVANT®?
Do not receive SYLVANT® if you have had a severe allergic reaction to siltuximab or any of the ingredients in SYLVANT®.
Before you receive SYLVANT®, tell your healthcare provider about all of your medical conditions, including if you:
have an infection. You should not receive SYLVANT® if you have a severe infection.
have had a recent vaccination or are scheduled to receive any vaccinations. You should not receive a live vaccine during your treatment with SYLVANT®.
have or have had any stomach or bowel (intestine) problems, such as diverticulitis or ulcers. Tell your healthcare provider if you have pain in your stomach area.
are pregnant or plan to become pregnant. It is not known if SYLVANT® will harm your unborn baby. You should not become pregnant while receiving treatment with SYLVANT®. Females who are able to become pregnant should use effective birth control during treatment with SYLVANT® and for 3 months after stopping treatment.
are breastfeeding or plan to breastfeed. It is not known if SYLVANT® passes into your breast milk. You and your healthcare provider should decide if you will take SYLVANT® or breastfeed. You should not do both.
Tell your healthcare provider about all of the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of SYLVANT®?
SYLVANT® may cause serious side effects, including:
Infections. SYLVANT® may lower your ability to fight infections. Tell your healthcare provider right away if you have any signs or symptoms of an infection during treatment with SYLVANT®.
Infusion and allergic reactions. If you have an infusion or allergic reaction while receiving SYLVANT®, your healthcare provider will stop your infusion and treat your reaction. If you have a severe infusion or allergic reaction your healthcare provider may stop your treatment completely. Tell your healthcare provider or get medical help right away if you have any of these symptoms during or after your infusion of SYLVANT®: back pain, chest pain or tightness, nausea and vomiting, flushing, redness, irregular heart beat (palpitations), trouble breathing, wheezing, dizziness or light-headedness, swelling of the lips, skin rash, headache or itching.
The most common side effects of SYLVANT® include: rash, itching, upper respiratory tract infection, swelling, weight gain, and increased blood level of uric acid.
Tell your healthcare provider if you have any side effect that bothers you or that does not go away.
These are not all the possible side effects of SYLVANT®. Call your doctor for medical advice about side effects.
General information about the safe and effective use of SYLVANT®
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about SYLVANT® that is written for health professionals.
Report any signs of new or worsening medical conditions to your healthcare provider.
You are encouraged to report negative side effects of prescription drugs to the FDA.
